Valuation : Abbott Laboratories

Market Cap 20TCr 17TCr 16TCr 15TCr 27TCr 18,85700Cr 27TCr 1,87900Cr 73TCr 9,50400Cr 74TCr 73TCr 31,45300Cr P/E 2026 *
32x
P/E 2027 * 24.7x
Enterprise Value 22TCr 19TCr 18TCr 16TCr 31TCr 21,14300Cr 31TCr 2,10700Cr 82TCr 10,65600Cr 83TCr 81TCr 35,26700Cr EV / Sales 2026 *
4.4x
EV / Sales 2027 * 4x
Free-Float
86.16%
Yield 2026 *
2.3%
Yield 2027 * 2.46%
1 week+0.18%
Current month+6.61%
1 month+8.14%
3 months+31.82%
6 months-0.36%
Current year-7.05%
1 week 95.52
Extreme 95.52
100.3
1 month 89.66
Extreme 89.66
100.3
3 years 69.64
Extreme 69.64
134.1
5 years 69.64
Extreme 69.64
134.1
10 years 34
Extreme 34.003
134.1
Manager TitleAgeSince
Chief Executive Officer 52 31/03/2020
Director of Finance/CFO 53 01/09/2023
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 09/12/2011
Director/Board Member 67 09/12/2011
Director/Board Member 71 16/02/2017
Change 5-day change 1-year change 3-year change Capi.($)
-2.43%+0.18%-13.47%+1.65% 20TCr
-2.20%-2.48%-15.20%+7.08% 20TCr
-2.23%-4.42%-2.40%+9.47% 12TCr
-2.00%+1.30%+10.88%+78.98% 6.26TCr
-2.00%-3.74%+27.02%+53.48% 5.24TCr
-1.09%+0.28%-3.06%-32.81% 5.18TCr
+0.37%-0.66%+17.30%-11.38% 3.36TCr
+0.20%+2.18% - - 3.03TCr
-1.09%-1.90%+41.55%-12.10% 2.46TCr
-0.47%+3.56%-3.25%+19.21% 2.38TCr
Average -0.95%+0.67%+6.60%+12.62% 6.6TCr
Weighted average by Cap. -1.35%+0.01%-3.25%+11.37%

Financials

2026 *2027 *
Net sales 5.03TCr 4.32TCr 4.04TCr 3.7TCr 6.97TCr 4,80400Cr 6.99TCr 48TCr 19TCr 2,42100Cr 19TCr 18TCr 8,01400Cr 5.46TCr 4.69TCr 4.39TCr 4.02TCr 7.58TCr 5,21900Cr 7.6TCr 52TCr 20TCr 2,63000Cr 21TCr 20TCr 8,70600Cr
Net income 623.24Cr 534.99Cr 500.86Cr 458.63Cr 863.97Cr 60TCr 866.42Cr 5.93TCr 2.32TCr 30TCr 2.34TCr 2.29TCr 99TCr 792.44Cr 680.23Cr 636.85Cr 583.15Cr 1.1TCr 76TCr 1.1TCr 7.54TCr 2.95TCr 38TCr 2.98TCr 2.91TCr 1,26200Cr
Net Debt 2.39TCr 2.05TCr 1.92TCr 1.76TCr 3.32TCr 2,28600Cr 3.33TCr 23TCr 8.91TCr 1,15200Cr 8.99TCr 8.79TCr 3,81400Cr 2.1TCr 1.8TCr 1.68TCr 1.54TCr 2.91TCr 2,00200Cr 2.91TCr 20TCr 7.8TCr 1,00900Cr 7.87TCr 7.7TCr 3,33900Cr
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
-
Date Price Change
28/26/28 95.64 -2.43%
26/26/26 €98.02 -1.41%
25/26/25 €99.42 -0.42%
24/26/24 €99.84 +0.30%
21/26/21 €99.54 +1.80%
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
114.10USD
Average target price
120.20USD
Spread / Average Target
+5.35%

Quarterly revenue - Rate of surprise